Aura Biosciences (AURA) is the lead sponsor of 5 active clinical trials listed on ClinicalTrials.gov[4], including 1 Phase 3[1], 1 Phase 2[2], 1 Phase 1[3].
Trial NCT06007690[5] evaluates Bel-sar in Choroidal Melanoma with a target enrollment of 100 participants.